Search Results 2531-2540 of 4128 for 搜索留痕最新技术咨询邮箱：lgooxc@hotmail.com

1. A Study of Nivolumab and Multi-fraction Stereotactic Radiosurgery with or without Ipilimumab in Treating Participants with Recurrent Grade II-III Meningioma - Mayo Clinic

   Monoclonal antibodies, such as nivolumab and ipilimumab, may interfere with the ability of tumor cells to grow and spread. Stereotactic radiosurgery is a ...

2. A Placebo-Controlled Trial of Pregabalin (Lyrica) for Irritable Bowel Syndrome - Mayo Clinic

   This study is being done to see if Lyrica helps people with irritable bowel syndrome. Participation eligibility. Participant eligibility includes age, gender, ...

3. Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer - Mayo Clinic

   Cobimetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving atezolizumab with cobimetinib may work better at ...

4. A Phase 2 Study to Evaluate Pharmacodynamics of YKP10811 in Patients With Chronic or Functional Constipation - Mayo Clinic

   About this study. This will be a single-center, randomized, parallel group, multiple dose administration, double-blind, placebo-controlled study to evaluate ...

5. Mayo Clinic Family Medicine Resident Wellness Study

   About this study. The objectives of this study are to better understand the association between sleep characteristics (sleep disruptions and deprivations) ...

6. Quality-Adjusted Survival in Allogeneic Hematopoietic Cell Transplant Patients - Mayo Clinic

   The main aim of this pilot study is to evaluate treatment-related toxicity and clinical indicators of QOL in HCT patients, and to integrate these into a ...

7. A Study to Evaluate Gevokizumab with Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers - Mayo Clinic

   A Study to Evaluate Gevokizumab with Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers · Overview.

8. Relapsed or High-Risk Myeloma Receiving Novel Immunotherapies Outcomes of Patients - Mayo Clinic

   immunotherapy and to assess selection differences, treatment sequencing and outcomes from salvage therapy after first or subsequent novel immunotherapy.

9. Clinical Research Study With Clazosentan to Evaluate Its Effects on Preventing Complications Due to the Narrowing of the Blood Vessels (Vasospasm) in the Brain, Caused by Bleeding Onto the Surface of the Brain (REACT) - Mayo Clinic

   Clinical Research Study With Clazosentan to Evaluate Its Effects on Preventing Complications Due to the Narrowing of the Blood Vessels (Vasospasm) in the Brain, ...

10. Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects with Recurrence of Clostridium difficile Infection - Mayo Clinic

    The purpose of this study is to evaluate the safety and effectiveness of CP101 treatment in adults who had a Clostridum difficile Infection (CDI) recurrence ...